Bifunctional pyridoxal derivatives with a charged side chain in the 5' position react specifically with the N-terminal valine residues of hemoglobin. Three of these compounds, which have only a single negative charge in the side chain, are highly selective for the a-chain N-terminal residues in the oxy conformation while pyridoxal phosphate, with two negative charges, reacts specifically with the , N-termini in deoxyhemoglobin. Schiff'sbase formation, therefore, results in decreased oxygen affinity with pyridoxal phosphate but increased oxygen affinity with the other three compounds. Reduction with sodium borohydride leads to irreversible coupling at either end of the molecule, and preparation and properties of such derivatives are described.
We have shown previously that pyridoxal phosphate is analogous to the naturally occurring cofactor 2,3-diphosphoglycerate in decreasing the oxygen affinity of hemoglobin (1) (2) (3) (4) . The two compounds compete for the same site in deoxyhemoglobiin, i.e., the entrance to the central cavity formed by the j# chains. While diphosphoglycerate is held by salt bridges to Val I#, His 2,3, and His 143g (5) , pyridoxal phosphate is linked by a Schiff's base to Val 1j# and, in addition, the phosphate forms a salt bridge, probably with Lys 82# (6) (Fig. 1) . Reduction of the Schiff's base results in covalent attachment of pyridoxal phosphate with permanent alteration in the oxygenation properties of the resulting hemoglobin (4) .
Pyridoxyl derivatives in which the aldehyde or the phosphate group, or both, is missing, such as pyridoxal, pyridoxamine phosphate, or pyridoxine, have no significant effect on ligand binding (4) .
We have now found that another group of pyridoxal derivatives has the opposite effect to that of pyridoxal phosphate on oxygenation of hemoglobin. A list of these compounds is shown in Table 1 .
EXPERIMENTAL
Hemoglobin was prepared from freshly drawn human blood as described (4) and freed of organic phosphates by the method of Berman et al. (15) The reversible reaction of pyridoxal compounds with hemoglobin was done in 0.1 M Tris at pH 7.3. Since Tris is a poor buffer at this pH (90% protonated) and Schiff's-base formation liberates protons, it is essential to readjust the pH after the components are mixed. Binding was measured by ultrafiltration (16) . Oxygenation curves were determined by the method of Benesch et al. (17) , with 20 min for equilibration to allow the reaction with pyridoxals to go to completion.
The irreversible modification of hemoglobin was conducted as described for pyridoxal phosphate (4) . An argon atmosphere was used for experiments with deoxyhemoglobin and 1% CO-99% N2 for those with liganded hemoglobin.
The pyridoxylated hemoglobin derivatives were isolated in the CO form by preparative isoelectric focusing in polyacrylamide gels (8) . They were eluted and converted to their oxy form by a procedure described elsewhere (8) . Unmodified hemoglobin from the same reaction mixture, isolated in the same way, served as a control.
Separation into subunits was done as described (9) . The mercurated reaction mixture was subjected to acrylamide-gel electrophoresis in a Tris-glycinate buffer at pH 9.6 for about 1 hr at room temperature (250) and scanned at 540 nm without staining.
Removal of heme, hydrolysis of globin, and ion exchange chromatography of the fluorescent amino acids and peptides have been described (4 Table 1 are shown in Fig.  2 . In contrast to pyridoxal phosphate, where the shift in the oxygenation curve clearly reflects its high affinity for the #-deoxy site, the other compounds increase the oxygen affinity, indicating preferential binding to the oxy conformation. Direct binding measurements confirm this conclusion (Fig. 3) . Pyridoxal sulfate binds to hemoglobin with a stoichiometry of 2 mol per tetramer and an affinity that is about 3-times greater for the liganded than for the deoxy form.
Irreversible Pyridoxylation of Hemoglobin and Location of the Binding Site. Reduction of the reversible Schiff's base with NaBH4 results in formation of a secondary amine with covalent attachment of the pyridoxyl residue to the protein.
For pyridoxal phosphate, the reaction with deoxyhemoglobin leads to specific substitution at the N-terminal valine residues of the ,B chain. In liganded hemoglobin, on the other hand, this specificity is lost and considerable coupling to the a N-terminal valinie occurs (4) .
The other pyridoxal derivatives show complete specificity for the N-terminal valines of the a chains in liganded hemoglobin. Dissociation into subunits yields only "fast" a chains but no abnormal (3 chains (Fig. 4) . The only fluorescent products obtained on acid hydrolysis of the globin from the "fast" a component were N-pyridoxyl valine and N-pyridoxyl valylleucine, but no pyridoxyl lysine was observed (Fig. 5) . These results unequivocally identify the a N-terminal valine As a result, at equilibrium the solution will contain 25% Hb(PLP)2, 50% Hb-PLP, and 25% Hb. Chromatography or any other method that discriminates on the basis of charge then displaces this equilibrium until only equal amounts of disubstituted and unsubstituted hemoglobin remain, l)rovided the rate of exchange is fast compared to the rate of separation.
Isoelectric focusing in acrylamide gels is particularly effective for isolation and purification of the CO derivatives of these chemically modified hemoglobins (8) . With this technique three bands are observed during the early stages of the separation, but the middle band disappears later with concomitant enrichment of the other two. The composition of these two bands was established by acrylamide-gel electrophoresis after dissociation into subunits by the method of Bucci (9) . The results are shown in Fig. 4A and D. Scan A is identical with that of normal hemoglobin, and scan D shows only fast # chains, but no normal ones, and gives no evidence of fast a chains. It therefore corresponds to a2(3PLP)2.
An analogous transformation involving asymmetric hybrids between hemoglobin variants of different charge has been described by Bunn (10) .
ii. a Substitution. The binding curves ill Fig. 3 show that liganded hemoglobin binds a second molecule of pyridoxal sulfate with an affinity comparable to the first. Therefore, reaction of COHb with 1.5 equivalents of pyridoxal sulfate per tetramer should give rise to a mixture of mono-and disubstituted derivatives.
On isoelectric focusing of such a reaction mixture, three major bands are observed even after 16 hr. The subunit composition of these bands is shown in Fig. 4A, B , and C. The first band (scan A) again corresponds to unsubstituted hemoglobin. The second one, with normal g chains and equal amounts of normal and fast a chains, is the monosubstituted a pyridoxylated derivative, aaPLS32(scan B). Finally, the composition of the third band is shown in scan C, where only normal p chains and fast a chains are evident. This band is therefore composed of (aPLS)2(2.
The persistence of the monosubstituted a derivative in contrast to the (3-substituted one, clearly demonstrates the stability of this asymmetric tetramer. Substitution with the bifunctional pyridoxal sulfate at one a N-terminus evidently inhibits the dissociation into dimers that is normally seen in liganded hemoglobin (7) .
Oxygenation Properties of a and Dipyridoxylated Hemoglobins. Fig. 6 (Table 2 ). This result is not surprising, since pyridoxylation introduces a negative charge in addition to blocking the N-terminal NH2 group. In the (-pyridoxal phosphate compound, the salt bridge between the phosphate residue and Lys 82(3 (Fig. 1 The superscript c refers to carbamylated derivatives (these data are from unpublished observations of J. V. Kilmartin. pso is the dxygen pressure at 50% oxygenation.
can take place and, therefore, the oxygen affinity is greatly lowered.
The p5o of the a-pyridoxal sulfate Hb, in contrast to the a-carbamylated one, is only slightly lower than that of unmodified hemoglobin. This result might be explained by the replacement of the salt bridge between the a N-terminal NH2 group and the a C-terminal COOH group in the deoxy conformation by a new one between the SO3-side chain and the guanidine residue of the C-terminal arginine as illustrated in Fig. 7 .
The pronounced difference in the oxygen affinity of the aand ,3-pyridoxylated derivatives would lead to the prediction that the environment of pyridoxal phosphate at the ( end is drastically influenced by oxygenation, but that this is not the case for pyridoxyl residues at the a end.
DISCUSSION
Perhaps the most surprising feature of the reaction of pyridoxal compounds with hemoglobin described here is their high degree of specificity for the N-terminal amino groups. In other proteins, notably pyridoxal-dependent enzymes, pyridoxal phosphate is invariably linked to the e-amino group of lysine (11) (12) (13) . The high stability of Schiff's bases between valine or isoleucine and pyridoxal found by Metzler (14) may be a factor in the selective binding of pyridoxal compounds by the N-terminal valine residues of hemoglobin.
Furthermore, it is clear that the conformation of the protein as well as the type of pyridoxal compound is crucial in achieving selective substitution of either the a or the (3 N-terminal valines. Pyridoxal phosphate with its doubly negative side chain satisfies the structural requirements of the X N-terminal site in deoxyhemoglobin and, therefore, shows a preferential affinity for this conformation. This is not the case with the other pyridoxal derivatives, all of which have only a single negative charge on the side chain in the 5' position. These do not react with the (3 N-termini even in the deoxy conformation, and coupling of these compounds is confined to the a chains, when rupture of salt links makes their N-terminal amino groups available in the oxy conformation. The negative side chains are then in a position to interact electrostatically with the guanido residues of the C-terminal arginines (Fig. 7) . Such a cross link might be responsible for the increased resistance of the a-substituted tetramers to dissociation into dimers.
